Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, DAX 40, Dow, Bitcoin,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, DAX 40, Dow, Bitcoin,
Quetzal Capital (QTZ), which has conditionally agreed to acquire Tap Global Limited, a regulated, crypto-fiat exchange service provider, notes recent developments in cryptocurrency markets concerning FTX Group and questions around
First healthy volunteers dosed on schedule
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Dax, Dow, Bitcoin, Aston,
DeepVerge (DVRG) said it notes recent market speculation regarding forthcoming loan repayments and a potential equity fundraising.
Evgen Pharma (EVG), a clinical-stage drug development company, has licensed the global rights for lead asset SFX-01 in neurodevelopmental disorders and schizophrenia to Stalicla SA, a Swiss company specialising in
SFX-01 licensing deal for up to $160.5m in milestone payments expands lead asset into neurodevelopmental disorders
Evgen Pharma plc (AIM: EVG), the clinical stage drug development company developing sulforaphane based medicines for the treatment of cancers and inflammation, announces that it has progressed discussions with the
We were treated to a late RNS arrival yesterday from Omega (ODX), the specialist medical diagnostics company, as it noted concerns regarding the ability of certain lateral flow tests to
It would appear that there is something of a land grab going on for Tirupati Graphite (TGR), the specialist graphite producer.
Publication shows effectiveness of SFX-01 in patient derived glioblastoma cells University of Auckland data
There was two for the price of one at pharma services group Open Orphan (ORPH), not only its hVIVO subsidiary signing a £5.7m contract with a specialist biotechnology company developing